+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Feminine Probiotic Supplement Market Size, Share and Growth Outlook, 2026: Analysis By Product Form (Capsules, Gummies, Tablets, Powders, Liquids), By Strain Type (Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Multi-strain Blends), By Application (Vaginal Health, Digestive Health, Urinary Tract Health, Hormonal Balance, Immunity Support), By Distribution Channel (Online Retail, Pharmacies & Drug Stores, Health & Wellness Stores, Specialty Nutrition Stores) Companies, and Country Forecast, 2021 to 2034

Global Feminine Probiotic Supplement Market size is forecast to increase from $1.73 Billion in 2026 to $3.27 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007197
Pages: 225 Pages

Feminine Hygiene Products Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Sanitary Napkins, Tampons, Panty Liners, Menstrual Cups, Feminine Hygiene Washes, Intimate Wipes), By Nature (Disposable, Reusable), By Consumer Orientation (Teenage, Adult), By Distribution Channel (Supermarkets, Pharmacies, Online Retail, Convenience Stores) Companies, and Country Forecast, 2021 to 2034

Global Feminine Hygiene Products Market size is forecast to increase from $32.38 Billion in 2026 to $51.22 Billion in 2034 at a CAGR of 5.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007196
Pages: 229 Pages

Female Sexual Dysfunction Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (PDE5 Inhibitors, Serotonin Agonists, Hormone Therapy , Others), By Indication (Hypoactive Sexual Desire Disorder , Female Orgasmic Disorder, Sexual Arousal Disorder, Dyspareunia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Female Sexual Dysfunction Treatment Market size is forecast to increase from $651.42 Million in 2026 to $1624.45 Million in 2034 at a CAGR of 12.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007195
Pages: 218 Pages

Female Infertility Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Gonadotropins, Clomiphene Citrate, Dopamine Agonists, Aromatase Inhibitors, GnRH Analogs), By Indication (Ovulatory Dysfunction, Polycystic Ovary Syndrome , Endometriosis, Uterine Fibroids, Primary Ovarian Insufficiency), By End User (Hospitals, Fertility Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Female Infertility Drugs Market size is forecast to increase from $3.3 Billion in 2026 to $5.42 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007194
Pages: 216 Pages

Female Fertility and Pregnancy Rapid Test Market Size, Share and Growth Outlook, 2026: Analysis By Product (Pregnancy Tests, Ovulation Prediction Kits, Fertility Monitors), By Technology (Lateral Flow Immunoassay, Digital, Microfluidics), By Distribution Channel (Retail Pharmacies, E-commerce, Supermarkets), By End User (Home Care, Hospitals, Fertility Clinics) Companies, and Country Forecast, 2021 to 2034

Global Female Fertility and Pregnancy Rapid Test Market size is forecast to increase from $1.78 Billion in 2026 to $2.53 Billion in 2034 at a CAGR of 4.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007193
Pages: 229 Pages

Female Contraceptive Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Contraceptive Drugs , Contraceptive Devices ), By Hormone Composition (Combined Hormonal Contraceptives , Progesterone-Only Contraceptives, Non-Hormonal ), By Duration of Action (Short-Acting Contraceptive Methods, Long-Acting Reversible Contraceptives , Permanent ), By Target User Age Group (15–19 Years, 20–29 Years, 30–39 Years, 40+ Years), By End-User (Home Use , Clinical Use) Companies, and Country Forecast, 2021 to 2034

Global Female Contraceptive Market size is forecast to increase from $31.66 Billion in 2026 to $59.47 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007192
Pages: 212 Pages

Feeding Tubes Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Nasoenteral Feeding Tubes , Enterostomy Feeding Tubes , Oroenteric Feeding Tubes, Low-Profile ), By Material Composition (Polyurethane Tubes, Silicone Tubes, Polyvinyl Chloride ), By Placement Technology (Endoscopic Placement, Surgical Placement, Radiological , Electromagnetic Tracking Placement), By Patient Demographics (Adult Patients, Pediatric Patients, Neonatal Cohorts), By Clinical Application (Oncology, Gastroenterology, Neurology & Neurodegenerative Disorders, Critical Care & Trauma, Metabolic & Hepatology Disorders), By End-User (Hospitals & Acute Care Units, Home Care Settings, Ambulatory Surgical Centers , Long-Term Care Facilities & Nursing Homes) Companies, and Country Forecast, 2021 to 2034

Global Feeding Tubes Market size is forecast to increase from $2.33 Billion in 2026 to $3.74 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007191
Pages: 216 Pages

Fecal Occult Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Guaiac Fecal Occult Blood Test , Fecal Immunochemical Test , Automated Feces Analyzer Testing Systems), By Clinical Application (Colorectal Cancer Screening, Gastrointestinal Bleeding Management, Anemia Evaluation), By Testing Location (Laboratory-Based Testing, Point-of-Care Testing ), By End-User (Hospitals & Inpatient Facilities, Clinical Diagnostic Laboratories & Pathology Centers, Physician Office Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Fecal Occult Testing Market size is forecast to increase from $1.61 Billion in 2026 to $2.85 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007190
Pages: 228 Pages

Fecal Calprotectin Test Market Size, Share and Growth Outlook, 2026: Analysis By Assay (Enzyme-Linked Immunosorbent Assay , Enzyme Fluoroimmunoassay , Quantitative & Semi-Quantitative Immunochromatography, Point-of-Care Testing ), By Clinical Indication (Inflammatory Bowel Disease Diagnosis & Monitoring, Irritable Bowel Syndrome , Colorectal Cancer Screening, Celiac Disease Management, Other Gastrointestinal Disorders), By System Modality (Laboratory-Based Automated Testing Systems, Standalone Rapid Testing Kits, Home-Based Patient Self-Testing Platforms ), By End-User (Diagnostic Laboratories & Reference Centers, Hospitals & Inpatient Gastrointestinal Clinics, Academic & Medical Research Institutes, Outpatient Care Facilities & Ambulatory Centers) Companies, and Country Forecast, 2021 to 2034

Global Fecal Calprotectin Test Market size is forecast to increase from $6.52 Billion in 2026 to $14.6 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007189
Pages: 210 Pages

Fatty Acid Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Product (Omega-3 Fatty Acids, Omega-6 Fatty Acids, Omega-9 Fatty Acids, Medium-Chain Triglycerides , Combined ), By Raw Material Source (Marine Oils , Krill Oil, Algal Oil , Flaxseed Oil, Others), By Application (Dietary Supplements, Fortified Food & Beverages, Infant Formula Ingredients, Pharmaceutical Formulations, Animal Feed Additives, Cosmetics & Personal Care Additives), By Core Clinical Indication (Cardiovascular , Cognitive & Brain Development, Joint Health & Anti-inflammation, Ocular , General Maternal & Prenatal Wellness), By Distribution Channel (Supermarkets, Hypermarkets, & Mega Retailers, Retail Pharmacies & Drugstores, Specialty Health & Nutrition Stores, E-Commerce Platforms & Online Direct-to-Consumer) Companies, and Country Forecast, 2021 to 2034

Global Fatty Acid Supplements Market size is forecast to increase from $9.28 Billion in 2026 to $18.9 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007188
Pages: 211 Pages